Brief: S&P Says Dexin China Outlook Revised To Negative, 'B' Rating Affirmed
Nov 3 (Reuters) - S&P:
* S&P SAYS DEXIN CHINA OUTLOOK REVISED TO NEGATIVE WITH
WEAKENING
CHINA PROPERTY MARKET HINDERING DELEVERAGING; 'B' RATING
AFFIRMED
* S&P - NEGATIVE OUTLOOK REFLECTS SLOWDOWN IN SALES AMID
TOUGH
OPERATING CONDITIONS IN CHINA MAY AFFECT DEXIN'S LEVERAGE
IMPROVEMENT
* S&P - BELIEVE DEXIN CHINA'S CONTRACTED SALES WILL REMAIN
WEAK
GIVEN FALLING PROPERTY DEMAND IN CHINA
Source text for Eikon: ID:
Further company coverage: 2019.HK
((reuters.briefs@thomsonreuters.com;))
Recent news on Dexin China Holdings
See all newsBrief: Listing Of Dexin China's Shares To Be Cancelled On 7 Jan, HKEX Says
Brief: Dexin China Says Fei Zhongmin Tendered His Resignation As An Executive Director
Brief: Dexin China Says Winding Up Order Against Company
Brief: Chinese Builder Dexin Receives Liquidation Order From HK Court - Bloomberg News
Brief: Dexin China Sees Net Loss Ranging From RMB1,900 Mln To RMB2,050 Mln For Year